Ascendis Pharma (NASDAQ:ASND) reported quarterly earnings results on February 11, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share…
Ascendis Pharma (NASDAQ:ASND) reported quarterly earnings results on February 11, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.64, missing the consensus estimate of $-0.06 by $0.58 per share. Revenue came in at $288.1M, missing the estimate of $289.7M.
Ascendis Pharma's stock moved following the earnings release. The stock currently trades at $213.99 with a market capitalization of $12.7B.
Current market data
NASDAQ · ASND
$261.23
Up: +$0.42 · +0.16%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·
